Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,345.24 -60.42 (-0.16%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
59,974.46 -3,201.71 (-5.07%) CMC Crypto 200
1,285.39 -53.67 (-4.01%)
Guardant Health, Inc. (GH)
After hours:
| Previous close | 18.19 |
| Open | 17.90 |
| Bid | 17.99 x 600 |
| Ask | 18.08 x 300 |
| Day's range | 17.61 - 18.33 |
| 52-week range | 15.81 - 41.06 |
| Volume | |
| Avg. volume | 1,948,542 |
| Market cap | 2.194B |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- Insider Monkey
20 Foods To Reduce Cancer Risk
In this article, we will be taking a look at the 2o foods to reduce cancer risk. If you do no want learn about the global and US cancer stats, head straight to the 5 Foods To Reduce Cancer Risk. Global and US Cancer Statistics According to data from the World Cancer Research Fund International, […]
- Associated Press Finance
A blood test for colon cancer performed well in a study, expanding options for screening
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths. It's already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
